ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.651,72
-0,16%
S&P 500
5.318,10
0,21%
Dow Jones
39.474,60
-0,50%
Euro vs US Dollar
1,08349
0,09%
Bitcoin
68.149,15
-1,39%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) News

PSNL

Personalis (PSNL)

Personalis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DatumZeitQuelleÜberschriftSymbolFirma
22/05/202415h05Business WirePersonalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024NASDAQ:PSNLPersonalis Inc
22/05/202403h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
22/05/202403h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
21/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
17/05/202422h05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
08/05/202422h01Business WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
08/05/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
24/04/202422h01Business WirePersonalis to Announce First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/03/202421h01Business WirePersonalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
28/03/202414h00Business WireData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:PSNLPersonalis Inc
26/03/202414h00Business WirePersonalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response MonitoringNASDAQ:PSNLPersonalis Inc
19/03/202421h43Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
28/02/202422h01Business WirePersonalis Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/02/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
14/02/202422h01Business WirePersonalis to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
31/01/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
31/01/202422h01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
30/01/202415h00Business WirePersonalis and ClearNote Health Announce Partnership to Advance Epigenomic TechnologyNASDAQ:PSNLPersonalis Inc
29/01/202422h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PSNLPersonalis Inc
17/01/202422h15Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
16/01/202415h05Business WirePersonalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling AssayNASDAQ:PSNLPersonalis Inc
10/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
09/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
05/01/202415h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
05/01/202415h05Business WirePersonalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash BalanceNASDAQ:PSNLPersonalis Inc
21/12/202323h15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
21/12/202323h12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
20/12/202300h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
20/12/202300h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/12/202322h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Kürzlich von Ihnen besucht

TG
BAYN
Bayer
TG
432
Arbor Metals
AMEX
XLE
Energy Select Sector SPDR
DBI
TDXP
Tec DAX
CCOM
US30
US 30
COIN
BTCUSD
Bitcoin
TG
RHM
Rheinmetall
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
PM
XAUUSD
Gold vs US Dollar
NYSE
DIS
Walt Disney
TG
D7G
Nel ASA
CCOM
SILVER
SILVER
TG
CBK
Commerzbank
NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten